title: Deletion analysis of Ad5 E1a transcriptional control region: impact on tumor-selective expression of E1a and E1b.
abstract: The regulatory sequences upstream of E1a, the first viral protein expressed upon infection of cells with adenovirus, have binding sites for multiple transcription factors including two binding sites for E2f and five binding sites for Pea3. We evaluated the impact of deletions, which remove one or more of these transcription factor-binding sites on the expression of E1a in a panel of tumor cells and non-transformed cells. We demonstrated that specific deletions in the E1a enhancer markedly reduced the expression of E1a in growth-arrested cells while having a minimal impact on the expression of E1a in a panel of tumor cells. In particular, deletion of a 50-bp region located from -305 to -255 upstream of the E1a initiation site resulted in marked reduction of E1a and E1b expression and cytolytic activity in growth-arrested cells, while retaining near wild-type of expression of E1a and E1b and cytolytic activity in tumor cells. This deletion removed two Pea3 sites and one E2f site. The characteristics of this vector, TAV-255, was compared with dl1520 (Onyx-015) and demonstrated restricted cytolytic activity in growth-arrested cells similar to dl1520 and superior cytolytic activity in a panel of tumor cell lines. In this current study, we demonstrate that TAV-255, an E1a enhancer deletion vector, possesses tumor selective expression of both E1a and E1b along with potent tumor-selective oncolytic activity.
authors.affiliation: UCSD Moores Cancer Center, Health Sciences Drive, La Jolla, CA 92093, USA. Fhedjran@ucsd.edu
authors.forename: F
authors.initials: F
authors.lastname: Hedjran
authors.forename: K
authors.initials: K
authors.lastname: Shantanu
authors.forename: R
authors.initials: R
authors.lastname: Tony
mesh_terms: D000256:Adenoviridae / Q000235:genetics / Q000378:metabolism; D017500:Adenovirus E1A Proteins / Q000235:genetics* / Q000378:metabolism; D017501:Adenovirus E1B Proteins / Q000235:genetics* / Q000378:metabolism; D000260:Adenoviruses, Human / Q000235:genetics* / Q000378:metabolism; D045744:Cell Line, Tumor; D002470:Cell Survival; D003588:Cytopathogenic Effect, Viral; D004742:Enhancer Elements, Genetic; D017353:Gene Deletion; D015972:Gene Expression Regulation, Neoplastic; D015967:Gene Expression Regulation, Viral; D023061:Gene Order; D005822:Genetic Vectors / Q000235:genetics / Q000378:metabolism; D057809:HEK293 Cells; D006801:Humans; D009154:Mutation; D009369:Neoplasms / Q000235:genetics* / Q000378:metabolism; D050504:Oncolytic Viruses / Q000235:genetics*; D012333:RNA, Messenger; D012045:Regulatory Sequences, Nucleic Acid / Q000235:genetics*; D014765:Viral Vaccines
chemical_list: D017500:Adenovirus E1A Proteins; D017501:Adenovirus E1B Proteins; D012333:RNA, Messenger; D014765:Viral Vaccines; C464532:dl1520